• Explain why asthmatic patients were used as a patient control group in this study of the role of psychiatric abnormality in patients with multiple chemical sensitivities (MCS).
M
ultiple Chemical Sensitivities (MCS), while lacking a consistently demonstrated organic etiology, is an array of symptoms involving multiple organ systems that are reported to occur after low-level exposure to chemical substances. Many clinicians regard the syndrome as having a psychiatric component and several cross-sectional studies have demonstrated psychiatric comorbidity among patients with MCS, including somatization, 1,2 anxiety, 3, 4 panic disorder, [5] [6] [7] phobic disorder, 8 and depression. 9 It has been suggested that current psychiatric illness may be a reaction to MCS rather than an explanation for the illness, 2, 10 given that up to 50% of MCS patients do not meet criteria for a current psychiatric disorder. 2, 11 For this reason, categorical psychiatric diagnoses remain controversial and of limited explanatory power for unexplained symptom syndromes such as MCS. 12 Continuous measures of personality traits associated with somatic symptoms may provide insight beyond psychiatric diagnoses into stable individual risk factors that could play a role in the development of MCS. The purpose of the present study is to compare current and lifetime psychiatric diagnoses and personality traits of MCS patients to asthmatics (as an organically ill control group) and healthy controls.
A second purpose of this study is to assess the neuropsychological performance of MCS patients. Although cognitive symptoms including impaired memory, attention and concentration are reported symptomatically among MCS patients, objective documentation of these disturbances has been inconsistent or lacking. 2, 9, [13] [14] [15] This inconsistency may be attributed to a variety of factors, to include lack of agreement in the research literature on rigorous criteria for subject selection and static assessment of neuropsychologic function even though disturbances in cognitive function are typically reported to wax and wane with exposures. Therefore, the present study includes the administration of a comprehensive battery of neuropsychological tests to strictly defined MCS subjects, medically ill (asthmatics) and healthy controls in an attempt to investigate further the neuropsychological functioning of MCS patients.
A number of personality traits such as neuroticism and alexithymia are hypothesized to be associated with unexplained somatic illnesses such as MCS. 4, [15] [16] [17] [18] [19] [20] [21] [22] For instance Bell et al 23 related the psychological trait of shyness to MCS, while Davidoff et al 24 associated MCS with negative affectivity or neuroticism. Neuroticism, a relatively stable trait, is defined as the general tendency to experience negative, distressing emotions and has been shown to be related to health complaints, independent of actual physical disease. 16, 17, 25 Alexithymia, on the other hand, refers to an inability to identify and describe feelings, difficulty in distinguishing between feelings and body sensations, restricted imaginative processes, and a cognitive style focused on external events. 26 Individuals who are high in alexithymia are expected to have difficulty distinguishing between somatic and emotional sources of stress 27 and alexithymia has been shown to predict persistent somatization 28 and somatoform pain disorder. 29 Salminen et al 30 reported that alexithymia is a constant trait, independent of an individual's psychological state.
In addition to personality characteristics, responses to bodily sensations have been hypothesized to contribute to unexplained somatic illnesses. For example, Simon et al 4 found scores on the Barsky Amplification Scale 31, 32 significantly greater for chemically sensitive individuals relative to controls. Amplification refers to hypervigilance to bodily sensations, a tendency to concentrate on relatively weak sensations, and the tendency to react to somatic sensations in a manner that intensifies them. Likewise, anxiety sensitivity, a feature of panic disorder, 33 is characterized as a fear of the physical sensations associated with panic such as dyspnea or chest tightness; these sensations are misinterpreted as being catastrophic, thus leading to a cycle of increasing anxiety as autonomic arousal escalates and eventually culminates in a panic attack. 34 Poonai et al 6 reports that patients with idiopathic environmental intolerance (or MCS) scored higher than controls on the Anxiety Sensitivity Index (ASI), 35 a questionnaire assessing anxiety-related physical sensations. Moreover, a group of investigators have noted increased anxiety and panic in MCS patients who were challenged either with their trigger substances, 36 lactate infusions, 5 or carbon dioxide inhalations. 6 In addition to measures of personality, several studies have documented an increased rate of lifetime and current Axis I psychiatric disorders 2-4,9 among MCS subjects relative to healthy controls or to other chronic pain or musculoskeletal injury control groups. To date, only one other study 37 of MCS subjects used asthmatics as a chronic illness control group. Asthmatics resemble MCS patients in the chronicity of their condition, their exacerbation of symptoms in response to environmental substances, and their tendency to avoid environmental triggers. 38 Asthmatics, however, report primarily respiratory symptoms (eg, bronchoconstriction) whereas the symptoms of MCS involve many organ systems to include the central nervous system. Thus, asthmatics provide a desirable comparison group by allowing control for lifestyle constrictions, as these have been hypothesized to play a role in the psychosocial and psychiatric symptoms of MCS.
Although most of the MCS research literature has focused on evaluation of psychiatric disorders, a few studies have objectively evaluated cognitive function with mixed results. Using a battery of cognitive tests (eg, verbal and visual memory, word finding), Brown-DeGagne and McGlone, 37 tested an olfactorylimbic model 39 and hypothesized relatively greater cognitive weaknesses associated with limbic (ie, frontaltemporal lobe) as opposed to nonlimbic (ie, posterior cortex) structures. These investigators reported no significant differences in cognitive function among MCS, asthmatics, and controls and furthermore, found the most support for the olfactory-limbic model among unmedicated asthmatics. Fiedler and colleagues documented verbal 14 or visual memory 9 decrements while a third study by Simon et al 40 also reported subtle differences in verbal learning. Simon et al, 40 however, found that after covarying current psychologic distress, no differences in memory function between MCS and musculoskeletal injury patients were noted. Current psychiatric distress was not covaried in the studies by Fiedler and colleagues. Thus, the subtle decrements documented by Fiedler and colleagues may also be secondary to comorbid psychiatric disorders such as anxiety and depression, or to personality traits. Finally, Bell et al, 41 reported slower reaction time on a divided attention task when a community elderly group reporting high intolerance to chemicals was compared to those reporting low chemical intolerance.
Most of the studies of neuropsychological function recruited a relatively small number of subjects who were selected by various criteria ranging from a score on the chemical odor intolerance scale 41 to the full Cullen case criteria. 9, 14 Thus, further exploration of cognitive function, in conjunction with assessment of psychiatric and personality factors, and comparing MCS, healthy controls, and asthmatics is warranted.
Methods

Subjects
Details of patient recruitment and a carefully designed set of diagnostic criteria are described in our previous paper. 42 Briefly, 30 MCS patients who met Cullen's 43 criteria for MCS, 19 asthmatics under the care of a pulmonologist or allergist, and 31 healthy controls were recruited to participate in a series of studies. MCS subjects were recruited from patients referred to the Environmental and Occupational Health Sciences Institute at Robert Wood Johnson Medical School. Asthmatics were recruited from letters sent to local pulmonologists as well as by advertisements in local newspapers. Healthy controls were recruited from the community in response to an advertisement posted in area newspapers. All subjects gave informed consent in compliance with Robert Wood Johnson Medical School Institutional Review Board procedures.
Each subject completed screening questions for MCS to include four questions regarding changes in lifestyle because of MCS (ie, diet, home furnishings, clothing, shopping) 4 and the Chemical Odor Intolerance Index (CII). 44 The CII is a questionnaire regarding the frequency (1 ϭ almost never; 2 ϭ rarely; 3 ϭ sometimes; 4 ϭ often; 5 ϭ almost always) of feeling ill from the odor of five substances (pesticides, paint, perfume, car exhaust, new carpeting). The score represents a total of the frequency ratings. Separate analyses of variance revealed that all groups differed significantly from one another on questions regarding lifestyle and chemical odor intolerance, with MCS subjects reporting the highest level of lifestyle changes and chemical odor intolerance followed by asthmatics and then controls (see Table 1 ). Subjects completed a confidential medical history questionnaire and received a physical examination, spirometry, and routine blood chemistry to include immunoglobin and complement levels. Based on the medical questionnaire and physical examination, no MCS or control subject had a diagnosis of asthma and no subject from any group had a diagnosis of serious concomitant medical disorders to include neurologic disease or brain injury, stroke or cardiovascular disease, serious pulmonary disease, hypertension, liver or kidney disease, serious gastrointestinal disorders (eg, colitis), diabetes, Lyme disease, significant toxic exposure, or a previously diagnosed major psychiatric disorder (ie, psychoses, organic mental disorder, bipolar disorder).
Measures
Personality and Psychiatric Function. Neuroticism, Extroversion, Openness Personality Inventory (NEO-PI): 45 This self-report questionnaire measures neuroticism as one of the domain scales assessed, and the present study used only this scale. It is composed of six facets including anxiety, hostility, depression, self-consciousness, impulsivity, and vulnerability. 46 Toronto Alexithymia Scale (TAS): 26 The TAS is a questionnaire which measures the ability to describe feelings, the ability to identify and distinguish between feelings and bodily sensations, the frequency of daydreaming, and the tendency toward externally oriented thinking. 47 Barsky Amplification Scale: 31, 32 This 10-item self-report questionnaire uses a Likert scale (1 ϭ not at all true to 5 ϭ extremely true) to assess somatosensory amplification with an emphasis on trait rather than state ratings of the items (ie, "I am often aware of various things happening in my body").
Anxiety Sensitivity Index (ASI): 35 This 16-item questionnaire determines one's level of fear of the consequences of experiencing anxi- ety symptoms (ie, "It scares me when my heart beats rapidly"). For instance, individuals scoring high on this scale would tend to interpret rapid heartbeat or palpitations as a sign of an impending heart attack while low scorers would interpret these same symptoms as merely unpleasant. 48 Items are rated on a Likert scale ranging from 0 (very little) to 4 (very much).
Diagnostic Interview Survey (DIS) from the Diagnostic and Statistical Manual of the American Psychiatric Association, 3rd Revision (DSM-III): 49 This highly structured survey evaluates psychiatric symptoms by assessing the clinical significance of reported symptoms, both currently (within the past 12 months) and during the subject's lifetime. By means of objective questions, the interviewer assesses whether the subject has sought health care for the symptom, taken medication for it, or felt that the symptom interfered significantly with activities. The interviewer determines whether the symptom was because of a medical condition or was the side effect of alcohol or drugs. As in our previously published study, 9 if the medical explanation given for a physical symptom was attributed to MCS or another medically unexplained somatic illness such as fibromyalgia or chronic fatigue, the symptom was regarded as psychiatric. If neither a medical nor physical condition or alcohol or drugs can account for the symptom then it constitutes criteria for a psychiatric disorder, which is determined to be current or lifetime. Diagnoses evaluated included agoraphobia, social and simple phobia, obsessive-compulsive disorder, panic disorder, generalized anxiety, major depression, dysthymia, drug/alcohol abuse/dependence, post-traumatic stress disorder, mania, and somatization.
Wahler Physical Symptoms Inventory (WPSI): 50 This self-report questionnaire measures the level or intensity of 42 physical symptoms associated with psychiatric disorders. The scale is based on somatic complaints that are considered to be consistent with complaints of psychiatric outpatients. Items for this scale were selected from a variety of sources and validated by a panel of mental health professions (eg, psychiatrists, social workers) as consistent with physical symptoms reported by psychiatric patients. 50 The respondent is asked to indicate the frequency with which he or she is bothered by a particular symptom, such as nausea, arm or leg aches or pains, or backaches, using a scale of 0 (almost never) to 5 (nearly every day).
Neuropsychological Function. Vocabulary: This subtest of the Wechsler Adult Intelligence ScaleRevised (WAIS-R) 51 requires the subject to explain the meaning of words presented orally and visually. This subtest was used as an estimate of pre-morbid intellectual functioning.
Block Design: Another subtest of the WAIS-R, 51 the Block Design test, is comprised of individual blocks that the subject must place together to reproduce two-dimensional designs. This test measures visuospatial ability and psychomotor speed.
Trail Making Test: 52 This test is used to assess visual search speed, attention, mental flexibility, and motor function. It consists of 25 encircled numbers randomly arranged on a page (Part A) and 25 encircled numbers and letters in alternating order (Part B). The subject is required to connect the stimulus circles in order as quickly as possible. Because Part A is used primarily as a test of motor speed, while Part B requires mental flexibility, scores on both parts were analyzed in the present study.
Paced Auditory Serial Addition Test (PASAT): 53 This test is a serialaddition task used to assess the rate of information processing and sustained attention. A pre-recorded tape delivers four trials with each presenting a random series of 50 numbers from 1 through 9. The subject is instructed to add pairs of numbers such that each number is added to the one immediately preceding it. In this extremely demanding task, the subject is required to comprehend the auditory input, respond verbally, inhibit encoding of one's own response while attending to the next stimulus in a series, and perform at an externally determined pace.
Digit Span: A subtest of the WAIS-R, 51 the Digit Span test consists of two parts; the subject is orally presented a string of digits and must repeat the same digits back to the examiner. The second part requires that the subject repeat a string of digits in reverse order from the presentation. This test measures short-term memory, attention, and concentration.
Continuous Visual Memory Test (CVMT): 54 This forced-choice test of visual recognition memory assesses immediate and delayed recall of abstract designs, in addition to accuracy of perceptual discrimination. Unlike other visual memory tasks, performance on this test does not require a graphomotor response and thus is not confounded by constructional ability.
Logical Memory Test: This subtest is part of the Wechsler Memory Scale-Revised (WMS-R) 55 and is composed of two parts. In Part I, the subject is read two short stories, one at a time, and asked to repeat the stories exactly as they were heard. In Part II, the subject is required to recall as much of the stories as possible after a 30-minute delay. Thus, the test assesses immediate and delayed recall of meaningfully organized material.
Rey-Osterrieth Complex Figure  Test : 56 The purpose of this test is to assess visuospatial construction ability and visual memory. The subject must copy the Rey-Osterrieth figure and then, without prior warning, reproduce it from memory. After a 30-minute delay, the subject must again reproduce the figure from memory.
California 
Procedure
Subjects were assessed with a psychiatric interview that incorporated the DIS from the DSM-III of the American Psychiatric Association 49 and with questionnaires assessing mood and personality. Neuropsychological testing was then performed by a trained psychometrician. Subjects also completed assessment of olfactory function, the results of which are reported separately. 42 
Statistical Analyses
Univariate analyses of variance (ANOVA) followed by post-hoc Duncan's Multiple Range Test were used to assess between-group differences for each of the individual personality and neuropsychological variables with P Յ 0.05 reported as significant. Chi-square analyses with Fisher's Exact Test were conducted on lifetime and current DIS scores.
Because age and education differed between the groups, these variables were initially correlated with the personality and neuropsychological measures. Age and education were not significantly correlated with measures of personality or with the Wahler Physical Symptom Inventory but were significantly correlated with neuropsychological measures. Therefore, to correct for the differences in age and education between the three groups, an analysis of covariance (ANCOVA) with age and education as covariates was conducted for all neuropsychological measures. Because many of the scores from the CVLT are highly correlated, a multivariate analysis of covariance (MANCOVA) was used initially to assess overall group differences followed by individual ANCOVAs with age and education as covariates. To assess the contribution of personality factors and chemical sensitivity to intensity of physical symptoms (ie, Wahler total score), a step-wise multiple regression using maximum R procedure was conducted using the following predictors: age, gender, years education, chemical odor intolerance index, neuroticism, anxiety sensitivity, alexithymia, and Barsky amplification scores.
Results
Axis I Psychiatric Disorders and Personality
Chi-square analyses comparing the proportion of psychiatric disorders, assessed with the DIS for DSM-III, (see Table 2 ) revealed that relative to controls, MCS subjects and asthmatics demonstrated a significantly greater proportion of lifetime anxiety disorders. The proportions of lifetime depression, drug/ alcohol abuse/dependence, and posttraumatic stress disorders were not significantly different between the groups nor was the overall rate of lifetime psychiatric disorders. For current psychiatric disorders (past 12 months), a higher proportion of MCS subjects met criteria for depression than either asthmatics or controls (ie, major depression or dysthymia). A significantly greater proportion of MCS subjects also met criteria for somatization disorder. Thus, relative to asthmatics and controls, MCS subjects met criteria for the greatest proportion of total current psychiatric disorders.
Separate analyses of variance revealed no significant differences between the groups on the Toronto Alexithymia Scale (see Table 3 ). For the Anxiety Sensitivity Index, MCS subjects and asthmatics were comparable and reported significantly higher anxiety sensitivity than controls. However, 5 MCS subjects and 2 controls also met criteria for current panic disorder or agoraphobia (see Table 2 ). Therefore, ASI scores were also compared among the groups excluding subjects with these disorders that are known to be associated with high ASI scores. Even with the exclusion of subjects with agoraphobia and panic disorder, the same pattern of results was observed. Mean scores for these scales, shown in Table 3 , support that MCS subjects and asthmatics report significantly more anxiety sensitivity than controls and appear to be similar in responses to bodily sensations of anxiety.
Analysis of variance comparing total scores on the Wahler Physical Symptoms Inventory revealed that MCS subjects reported significantly higher levels of somatic complaints than asthmatics, who, in turn, reported higher levels than controls. Thus, independent of specific exposures, MCS subjects and asthmatics report being bothered by physical distress more often than controls.
A step-wise regression to predict the Wahler total score was conducted with age, gender, education, personality, and chemical odor intolerance as predictors. Among these variables, chemical odor intolerance (partial r 2 ϭ 0.54; P Յ 0.0001) and anxiety sensitivity (partial r 2 ϭ 0.05; P Յ 0.003) were significant predictors of physical symptom reporting on the Wahler Physical Symptom Inventory, accounting for 59% of the variance.
Neuropsychological Measures
The means and standard deviations for the neuropsychological variables are shown in Table 4 with least squares means from the analyses of covariance in parentheses. Separate analyses of covariance with group as the between subjects factor and age and education as the covariates revealed that MCS subjects recalled significantly fewer words on the CVLT (CVLT Total) than asthmatics but neither MCS subjects nor asthmatics differed from controls. No other significant differences were noted for objective measures of neuropsychological performance. However, MCS subjects reported significantly more memory problems than controls on two of the four Metamemory Questionnaire scales. No differences in self-reported memory problems between asthmatics and controls or MCS subjects and asthmatics were found on any of the scales. Specifically, MCS subjects and asthmatics perceived significantly more problems with attention/ prospective memory than controls, with asthmatics reporting memory complaints that fell between but were not significantly different from controls' or MCS subjects' on retrograde memory. No group differences were found for questions of anterograde and historical memory.
To further explore the differences between the performance of asthmatics and MCS subjects on the CVLT, individual scores from Factor I 57 of this measure were analyzed with MANCOVA followed by individual ANCOVAs (Table 5 ). The overall MANCOVA revealed a significant overall difference among groups. On the individual ANCOVAs, the MCS subjects scored significantly lower than the asthmatics, but not controls on the following measures: short and long delay free and cued recall of List A and recognition memory. MCS subjects recognized fewer words and performed more poorly than asthmatics when asked to recall the list after both a short and long delay, with or without cues.
Because a significant proportion of MCS subjects was diagnosed with current depression which has been documented to produce mild deficits in verbal memory, 59 analyses were conducted to explore the effects of depression on the neuropsychologi- cal tests where performance differed between the groups. When MCS subjects with depression (n ϭ 12) were compared to MCS subjects without depression (n ϭ 18) and asthmatics (n ϭ 17; 2 depressed excluded), CVLT differences between the groups were similar to those seen in the analysis comparing all MCS subjects, asthmatics and controls. That is, MCS-depressed subjects performed worse than MCS-without depression subjects or asthmatics on the CVLT total, short and long free and cued recall and CVLT recognition (see Table 6 for means and standard deviations). Thus, MCSdepressed subjects did not encode the original list of words as well as MCS-without depression subjects and asthmatics and therefore, could not recall or recognize the words as well as the other groups.
Discussion
The present study contributes to the emerging picture of MCS by suggesting that anxiety and depression play a significant role in the physical and cognitive symptoms reported by MCS patients. As in previous work 2,3,9 a higher proportion of MCS subjects met diagnostic criteria for current depression and somatization than controls but again approximately 50% of subjects did not meet criteria for any current psychiatric disorder. However, similar to the findings of Poonai et al, 6 MCS subjects were significantly more sensitive to symptoms of anxiety and panic than controls even after subjects who met criteria for either current panic disorder or agoraphobia were removed from the analysis. These data suggest that even when patients do not meet criteria for a psychiatric disorder, dispositions associated with these psychiatric disorders may nevertheless be contributing to symptoms.
The present data cannot address the causal relationship between psychiatric disorders and MCS. However, given the poorly understood and uncontrolled nature of MCS, both depression and anxiety may represent a reaction to the frustration of this disorder. Moreover, the comparable level of anxiety sensitivity between MCS subjects and asthmatics suggests that both exogenous, uncontrolled exposures and fear of symptoms contribute to the clinical picture of both disorders.
Anxiety sensitivity among MCS subjects and asthmatics in the present study and the idiopathic environmental intolerance (IEI) subjects recruited by Poonai et al, 6 while significantly different from controls, was comparable to the average level of clinical samples diagnosed with social phobias or general anxiety, but was significantly below the average anxiety sensitivity scores of subjects diagnosed with agoraphobia or panic disorder (MCS with Panic/Agoraphobia (n ϭ 5): mean ASI ϭ 25.2; Clinical samples of Panic/Agoraphobia: mean ϭ 36.6; S.D. ϭ 12.3). 60 When the MCS subjects with panic or agoraphobia were removed from the analysis, ASI scores remained significantly greater for the MCS subjects than controls in the present study, whereas the IEI subjects who did not panic with CO 2 inhalation in the Poonai et al 6 study had ASI scores comparable to those of con- trols. This difference could be attributed to the use of psychiatric interviews rather than inhalation challenge to identify panic and further suggests that undiagnosed panic disorder as well as subclinical sensitivity to symptoms of anxiety could be factors in the clinical presentation of some MCS patients and asthmatics.
Results of the WPSI, a scale based on somatic complaints associated with psychiatric disorders revealed that MCS subjects rated their physical symptoms significantly higher 61 However, for MCS patients this response tends to be attributed more to psychiatric causes, perhaps a result of the lack of an identified organic basis to the illness.
Of note in this study as well was the number of MCS subjects who met criteria for a drug or alcohol abuse/dependence. Previous clinical studies have suggested that MCS subjects may be uniquely sensitive to medications and alcohol in a manner similar to xenobiotic chemicals. While an earlier study found no previous alcohol/substance abuse in the sample of MCS subjects, 9 with the exception of this study, only one other study directly evaluated substance abuse among MCS subjects and reported a markedly lower rate (4%) compared to controls. 3 Differences in the rate of substance abuse between the current and previous study 9 may be a result of the higher proportion of males in the present study (8/30 ; 27% in present study versus 4/36; 11% in 1996 study). In the current study, 50% (3/6) of the subjects who met criteria for lifetime substance abuse/dependence were male. This proportion suggests that males, who more infrequently present for clinical study of MCS, may also have a different premorbid profile than female MCS subjects.
The current study found subtle decrements in list learning and recall among MCS relative to asthmatics but not relative to healthy controls. Although this finding of subtle verbal learning and memory decrements has been observed in previous studies, 40, 14 it has not been a consistent finding. 9, 37 Furthermore, performance on Logical Memory, another test of immediate and delayed verbal memory, was also not significantly different between MCS and asthmatics or MCS and controls in either this study or that by Brown-DeGagne. 37 Finally, the finding by Bell et al 41 of impaired attention among elderly subjects who are chemically intolerant has not been replicated in either this or any other study where attention was evaluated among MCS subjects. This discrepancy may be attributable to the fact that Bell's sample was older than most MCS samples from other studies. It seems unlikely that chemical intolerance alone can account for impaired attention observed by Bell and colleagues because their sample was markedly less chemically intolerant than the MCS subjects in the present study (mean chemical intolerance 11.7 Ϯ 2.9 for Bell sample; mean chemical intolerance ϭ 20.79 Ϯ 2.74 for current MCS subjects).
When decrements in verbal learning and memory were reported by Simon et al, 40 current psychiatric distress accounted for the differences in memory performance between MCS subjects and musculoskeletal controls. In the present study, when the performance of MCS with and without depression was compared to asthmatics without depression, those MCS without depression performed similarly to asthmatics. Although Brown-DeGagne and McGlone 37 reported significant differences between MCS and controls on the Beck Depression Inventory 62 and the Beck Anxiety Inventory, 63 unlike the present study, they did not find an association between either measure of psychiatric distress and memory performance. However, in the present study, subjects were diagnosed with depression based on DSM-III criteria, and MCS subjects were then sub-grouped based on this diagnosis. Thus, it is possible that this method maximized the differences between groups as compared to the use of a score of depression as a covariate. Moreover, the MCS subjects in the Brown-DeGagne and McGlone 37 study did not report significantly more depression than asthmatics and did not perform differently from asthmatics or controls on a simpler measure of verbal learning, ie, Logical Memory, than the measure used in the present study, ie, CVLT (list learning). Thus, both differences in verbal memory task difficulty and method for the assessment of depression may account for these inconsistent results. If, as has been reported by MCS patients, decrements in cognitive performance are most evident with acute exposures, then neither the present study nor any of the previous studies have used methods that would allow evaluation of this clinical report.
A consistent finding with BrownDeGagne and McGlone, 37 however, is that MCS subjects (with and without depression) perceived their working and immediate memory and recall of previous verbal information to be significantly worse than controls' even though their performance on objective tests of memory did not differ from that of controls. Of note, MCS subjects in the present study did not self-report significantly more memory problems than asthmatics despite poorer memory performance primarily because asthmatics incorrectly perceived more memory problems than indicated by objective tests. These results are not surprising given that Otto et al 59 found CVLT scores for subjects with major depression to be between one-half and one standard deviation below ageand sex-corrected norms for nondepressed populations. These authors and Brown-DeGagne and McGlone 37 also reported that severity of depression was not associated with memory performance, but was associated with self-reported cognitive difficulty. Rourke, Halman, and Bassel 64 compared subjective memory complaints with CVLT performance and Beck Depression Inventory (BDI) 65 scores and found that subjects with higher memory complaints and impaired CVLT performance had elevations on the BDI as well.
Regardless of the etiology of MCS, the current results suggest that if the anxiety and depression that accompanies MCS is treated, both physical and cognitive symptoms could be improved. No one denies the impact of environmental pollutant exposures on exacerbation of asthma. However, if anxiety fuels responses to these exposures, symptoms and function will be worse and in the case of asthma may increase unwarranted use of rescue medication. For both MCS and asthma fear may also increase avoidance behavior which further compromises function. This does not imply that practitioners should blame the victim but rather that patients and clinicians need to optimize recognition and separation of fear-based from physically-based symptoms.
